Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal

Anne-Maree Kelly, Oene Van Meer, Gerben Keijzers, Justina Motiejunaite, Peter Jones, Richard Body, Simon Craig, Mehmet Karamercan, Sharon Klim, Veli-Pekka Harjola, Verschuren Franck, Anna Holdgate, Michael Christ, Adela Golea, Colin A Graham, Jean Capsec, Cinzia Barletta, Luis Garcia-Castrillo, Win Sen Kuan, Said Laribi & 1 muut on behalf of the AANZDEM and EuroDEM study groups

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Kuvaus

ABSTRACT Objectives Exacerbations of chronic obstructive pulmonary disease (COPD) are common in emergency departments (ED). Guidelines recommend administration of inhaled bronchodilators, systemic corticosteroids and antibiotics along with non-invasive ventilation (NIV) for patients with respiratory acidosis. We aimed to determine compliance with guideline recommendations for patients with treated for COPD in ED in Europe (EUR) and South East Asia/Australasia (SEA) and to compare management and outcomes. Methods In each region, an observational prospective cohort study was performed that included patients presenting to EDs with the main complaint of dyspnoea during three 72-hour periods. This planned sub-study included those with an ED primary discharge diagnosis of COPD. Data were collected on demographics, clinical features, treatment, disposition and in-hospital mortality. We determined overall compliance with guideline recommendations and compared treatments and outcome between regions. Results 801 patients were included from 122 EDs (66 EUR and 46 SEA). Inhaled bronchodilators were administered to 80.3% of patients, systemic corticosteroids to 59.5%, antibiotics to 44% and 60.6% of patients with pH
Alkuperäiskielienglanti
LehtiInternal Medicine Journal
Numeroj
ISSN1444-0903
DOI - pysyväislinkit
TilaJulkaistu - 15 huhtikuuta 2019
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3121 Sisätaudit

Lainaa tätä

Kelly, A-M., Van Meer, O., Keijzers, G., Motiejunaite, J., Jones, P., Body, R., ... groups, O. B. O. T. AANZDEM. A. EEM. S. (2019). Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal. Internal Medicine Journal, (j). https://doi.org/10.1111/imj.14323
Kelly, Anne-Maree ; Van Meer, Oene ; Keijzers, Gerben ; Motiejunaite, Justina ; Jones, Peter ; Body, Richard ; Craig, Simon ; Karamercan, Mehmet ; Klim, Sharon ; Harjola, Veli-Pekka ; Franck, Verschuren ; Holdgate, Anna ; Christ, Michael ; Golea, Adela ; Graham, Colin A ; Capsec, Jean ; Barletta, Cinzia ; Garcia-Castrillo, Luis ; Kuan, Win Sen ; Laribi, Said ; groups, on behalf of the AANZDEM and EuroDEM study. / Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal. Julkaisussa: Internal Medicine Journal. 2019 ; Nro j.
@article{3fa499669270424daf90ea9dc7d9d88a,
title = "Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal",
abstract = "ABSTRACT Objectives Exacerbations of chronic obstructive pulmonary disease (COPD) are common in emergency departments (ED). Guidelines recommend administration of inhaled bronchodilators, systemic corticosteroids and antibiotics along with non-invasive ventilation (NIV) for patients with respiratory acidosis. We aimed to determine compliance with guideline recommendations for patients with treated for COPD in ED in Europe (EUR) and South East Asia/Australasia (SEA) and to compare management and outcomes. Methods In each region, an observational prospective cohort study was performed that included patients presenting to EDs with the main complaint of dyspnoea during three 72-hour periods. This planned sub-study included those with an ED primary discharge diagnosis of COPD. Data were collected on demographics, clinical features, treatment, disposition and in-hospital mortality. We determined overall compliance with guideline recommendations and compared treatments and outcome between regions. Results 801 patients were included from 122 EDs (66 EUR and 46 SEA). Inhaled bronchodilators were administered to 80.3{\%} of patients, systemic corticosteroids to 59.5{\%}, antibiotics to 44{\%} and 60.6{\%} of patients with pH",
keywords = "Dyspnoea, emergency department, management, COPD, outcome, 3121 Internal medicine",
author = "Anne-Maree Kelly and {Van Meer}, Oene and Gerben Keijzers and Justina Motiejunaite and Peter Jones and Richard Body and Simon Craig and Mehmet Karamercan and Sharon Klim and Veli-Pekka Harjola and Verschuren Franck and Anna Holdgate and Michael Christ and Adela Golea and Graham, {Colin A} and Jean Capsec and Cinzia Barletta and Luis Garcia-Castrillo and Kuan, {Win Sen} and Said Laribi and groups, {on behalf of the AANZDEM and EuroDEM study}",
year = "2019",
month = "4",
day = "15",
doi = "10.1111/imj.14323",
language = "English",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "j",

}

Kelly, A-M, Van Meer, O, Keijzers, G, Motiejunaite, J, Jones, P, Body, R, Craig, S, Karamercan, M, Klim, S, Harjola, V-P, Franck, V, Holdgate, A, Christ, M, Golea, A, Graham, CA, Capsec, J, Barletta, C, Garcia-Castrillo, L, Kuan, WS, Laribi, S & groups, OBOTAANZDEMAEEMS 2019, 'Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal' Internal Medicine Journal, Nro j. https://doi.org/10.1111/imj.14323

Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal. / Kelly, Anne-Maree; Van Meer, Oene; Keijzers, Gerben; Motiejunaite, Justina; Jones, Peter; Body, Richard; Craig, Simon; Karamercan, Mehmet; Klim, Sharon; Harjola, Veli-Pekka; Franck, Verschuren; Holdgate, Anna; Christ, Michael; Golea, Adela; Graham, Colin A; Capsec, Jean; Barletta, Cinzia; Garcia-Castrillo, Luis; Kuan, Win Sen; Laribi, Said; groups, on behalf of the AANZDEM and EuroDEM study.

julkaisussa: Internal Medicine Journal, Nro j, 15.04.2019.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Get With The Guidelines - Management Of COPD In EDs In Europe And Australasia is sub-optimal

AU - Kelly, Anne-Maree

AU - Van Meer, Oene

AU - Keijzers, Gerben

AU - Motiejunaite, Justina

AU - Jones, Peter

AU - Body, Richard

AU - Craig, Simon

AU - Karamercan, Mehmet

AU - Klim, Sharon

AU - Harjola, Veli-Pekka

AU - Franck, Verschuren

AU - Holdgate, Anna

AU - Christ, Michael

AU - Golea, Adela

AU - Graham, Colin A

AU - Capsec, Jean

AU - Barletta, Cinzia

AU - Garcia-Castrillo, Luis

AU - Kuan, Win Sen

AU - Laribi, Said

AU - groups, on behalf of the AANZDEM and EuroDEM study

PY - 2019/4/15

Y1 - 2019/4/15

N2 - ABSTRACT Objectives Exacerbations of chronic obstructive pulmonary disease (COPD) are common in emergency departments (ED). Guidelines recommend administration of inhaled bronchodilators, systemic corticosteroids and antibiotics along with non-invasive ventilation (NIV) for patients with respiratory acidosis. We aimed to determine compliance with guideline recommendations for patients with treated for COPD in ED in Europe (EUR) and South East Asia/Australasia (SEA) and to compare management and outcomes. Methods In each region, an observational prospective cohort study was performed that included patients presenting to EDs with the main complaint of dyspnoea during three 72-hour periods. This planned sub-study included those with an ED primary discharge diagnosis of COPD. Data were collected on demographics, clinical features, treatment, disposition and in-hospital mortality. We determined overall compliance with guideline recommendations and compared treatments and outcome between regions. Results 801 patients were included from 122 EDs (66 EUR and 46 SEA). Inhaled bronchodilators were administered to 80.3% of patients, systemic corticosteroids to 59.5%, antibiotics to 44% and 60.6% of patients with pH

AB - ABSTRACT Objectives Exacerbations of chronic obstructive pulmonary disease (COPD) are common in emergency departments (ED). Guidelines recommend administration of inhaled bronchodilators, systemic corticosteroids and antibiotics along with non-invasive ventilation (NIV) for patients with respiratory acidosis. We aimed to determine compliance with guideline recommendations for patients with treated for COPD in ED in Europe (EUR) and South East Asia/Australasia (SEA) and to compare management and outcomes. Methods In each region, an observational prospective cohort study was performed that included patients presenting to EDs with the main complaint of dyspnoea during three 72-hour periods. This planned sub-study included those with an ED primary discharge diagnosis of COPD. Data were collected on demographics, clinical features, treatment, disposition and in-hospital mortality. We determined overall compliance with guideline recommendations and compared treatments and outcome between regions. Results 801 patients were included from 122 EDs (66 EUR and 46 SEA). Inhaled bronchodilators were administered to 80.3% of patients, systemic corticosteroids to 59.5%, antibiotics to 44% and 60.6% of patients with pH

KW - Dyspnoea

KW - emergency department

KW - management

KW - COPD

KW - outcome

KW - 3121 Internal medicine

U2 - 10.1111/imj.14323

DO - 10.1111/imj.14323

M3 - Article

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - j

ER -